4 Largecap Operating Margin Above 30 Per Cent Stocks to Watch for Future Multibagger Potential: Sun Pharma, HAL, Hindustan Zinc and Indian Hotels

Operating margin above 30 per cent stocks to watch for multibagger potential start with a simple filter: size, a clean financial record and earnings that keep growing. Sun Pharma, HAL, Hindustan Zinc and Indian Hotels meet that test, with market caps from Rs 1.10 lakh crore to Rs 4.18 lakh crore and Sun Pharma offering the fastest profit growth, 35.75% a year since FY22. Each of these companies has an FY26 operating profit margin above 30 per cent, a return on equity of at least 10 per cent and profit growth in FY26 and in the latest quarter, and net profit rose in FY26 and in the latest quarter.

This list covers companies with an FY26 operating profit margin above 30 per cent, a return on equity of at least 10 per cent and profit growth in FY26 and in the latest quarter, rising profit in FY26 and the latest quarter, market capitalisation above Rs 1,00,000 crore, and complete, verifiable financials, ranked by market capitalisation. Each company has a market cap above Rs 1 lakh crore. Investors screening operating margin above 30 per cent stocks usually begin with size and balance sheet strength, and this list follows the same logic. All figures are as of 26 October 2026 and are drawn from NSE and BSE data and company filings.

Click Here – Get Free Investment Predictions

What Are Operating Margin Above 30 Per Cent Stocks and Why Do They Attract Multibagger Interest?

Operating margin above 30 per cent stocks are shares of large companies that kept more than 30 paise of operating profit from every rupee of sales in FY26, margins that few businesses can match. The four here cover pharmaceuticals, defence aerospace, zinc mining and hotels.

A margin above 30 per cent points to a business with strong pricing power and a lasting edge over rivals. For operating margin above 30 per cent stocks, both FY26 and the latest quarter showed growth. Whichever way you read operating margin above 30 per cent stocks, the common thread is rising profit backed by complete financial data. For operating margin above 30 per cent stocks, checking each result against the latest quarter matters more than any single ratio. The next sections explain what stands out in each of operating margin above 30 per cent stocks, using FY26 and latest quarter data. Prices move daily, so recheck the figures for operating margin above 30 per cent stocks before you decide.

Operating Margin Above 30 Per Cent Stocks at a Glance: Price, Market Cap, PE and ROE

Prices are closing prices as of 26 October 2026. Hindustan Zinc combines the lowest PE of the group, 12.59, with the highest return on equity, 61.13%.

Stock	CMP (Rs)	Market Cap (Rs Cr)	PE	Industry PE	ROE	Debt to Equity	52-Week Range (Rs)
Sun Pharmaceutical Industries	1,740	4,18,102	34.50	36.42	13.74%	0.06	1,583.70 to 2,046.90
Hindustan Aeronautics	4,775	3,26,218	35.00	48.59	22.21%	0.00	3,479.10 to 5,149.90
Hindustan Zinc	497	2,14,904	12.59	12.27	61.13%	0.39	412.25 to 609.05
Indian Hotels Company	795.50	1,10,254	47.75	36.77	15.97%	0.22	568.70 to 971.00

Sun Pharma: 35.75% Profit CAGR Since FY22

Sun Pharmaceutical Industries is one of India's largest drugmakers and sells generic and specialty medicines in India and overseas. It reported FY26 revenue of Rs 61,673.94 crore, up 12.69% year on year, and net profit of Rs 11,564.52 crore, up 5.32%. Net profit has compounded at 35.75% a year since FY22, while revenue has grown 11.62% a year. Operating margin was 31.47% in FY26. The debt-to-equity ratio is 0.06, which keeps interest costs low.

In the June 2026 quarter, revenue rose 11.93% to Rs 16,023.50 crore and net profit grew 26.41% to Rs 2,910.80 crore. The share price has gained 110.81% over five years. Domestic institutions raised their holding from 20.23% in September 2025 to 22.27% in September 2026. The stock trades at a PE of 34.50 against an industry PE of 36.42, below the sector average, with a return on equity of 13.74%.

HAL: Return on Equity of 22.21%

Hindustan Aeronautics is India's state-owned aerospace company that designs, makes and services fighter jets, helicopters, engines and avionics. It reported FY26 revenue of Rs 36,787.95 crore, up 9.68% year on year, and net profit of Rs 9,115.52 crore, up 8.98%. Net profit has compounded at 15.74% a year since FY22, while revenue has grown 9.48% a year. Operating margin was 40.89% in FY26. The debt-to-equity ratio is 0.00, which keeps interest costs low.

The stock trades at a PE of 35.00 against an industry PE of 48.59, below the sector average, with a return on equity of 22.21%. In the June 2026 quarter, revenue rose 15.26% to Rs 6,415.41 crore and net profit grew 14.88% to Rs 1,589.66 crore. The share price has gained 607.71% over five years. Domestic institutions raised their holding from 8.71% in September 2025 to 12.56% in September 2026.

Hindustan Zinc: Return on Equity of 61.13%

Hindustan Zinc is among the world's largest integrated zinc producers and also produces lead and silver. It reported FY26 revenue of Rs 41,934 crore, up 19.59% year on year, and net profit of Rs 13,832 crore, up 33.60%. Net profit has compounded at 9.48% a year since FY22, while revenue has grown 8.15% a year. Operating margin was 56.75% in FY26. The debt-to-equity ratio is 0.39.

In the June 2026 quarter, revenue rose 74.70% to Rs 14,063 crore and net profit grew 144.81% to Rs 5,469 crore. Foreign investors raised their holding from 1.31% in September 2025 to 2.36% in September 2026. The stock trades at a PE of 12.59 against an industry PE of 12.27, with a return on equity of 61.13%. The dividend yield is 1.97%.

Indian Hotels: Quarterly Profit Up 22.39%

Indian Hotels Company, part of the Tata Group, runs Taj, SeleQtions, Vivanta and Ginger hotels and resorts. It reported FY26 revenue of Rs 9,971.43 crore, up 16.42% year on year, and net profit of Rs 2,195.14 crore, up 11.93%. Revenue has compounded at 32.74% a year since FY22. Operating margin was 35.53% in FY26. The debt-to-equity ratio is 0.22.

The stock trades at a PE of 47.75 against an industry PE of 36.77, with a return on equity of 15.97%. In the June 2026 quarter, revenue rose 15.09% to Rs 2,419.37 crore and net profit grew 22.39% to Rs 390.93 crore. The share price has gained 658.38% over five years. Domestic institutions raised their holding from 18.52% in June 2025 to 24.59% in June 2026.

Operating Margin Above 30 Per Cent Stocks: Financial Comparison on Growth and Margins

The table compares scale and growth across these operating margin above 30 per cent stocks. Latest quarter means the most recent reported quarter for each company, and only metrics that are positive for every company are shown.

Stock	Revenue (Rs Cr)	Net Profit (Rs Cr)	Revenue Growth (YoY)	4-Year Revenue CAGR	Latest Quarter Revenue Growth	Operating Margin (Latest Quarter)
Sun Pharma	61,673.94	11,564.52	12.69%	11.62%	11.93%	32.52%
HAL	36,787.95	9,115.52	9.68%	9.48%	15.26%	44.22%
Hindustan Zinc	41,934	13,832	19.59%	8.15%	74.70%	64.19%
Indian Hotels	9,971.43	2,195.14	16.42%	32.74%	15.09%	32.19%

Check the Univest Screener for live data on these operating margin above 30 per cent stocks

Institutional Holding in Sun Pharma, HAL, Hindustan Zinc and Indian Hotels

Institutional holding shows who is backing these operating margin above 30 per cent stocks alongside the promoter. The table uses the latest reported quarter for each. Indian Hotels has the deepest institutional backing, with FII and DII together holding 46.30% as of June 2026. Domestic institutions increased their holding over the past year in Sun Pharma (from 20.23% to 22.27%), HAL (from 8.71% to 12.56%) and Indian Hotels (from 18.52% to 24.59%).

Stock	Promoter	FII	DII	Public	Quarter
Sun Pharma	52.68%	14.36%	22.27%	10.70%	September 2026
HAL	71.64%	9.42%	12.56%	6.38%	September 2026
Hindustan Zinc	60.71%	2.36%	4.85%	32.07%	September 2026
Indian Hotels	38.12%	21.71%	24.59%	15.58%	June 2026

Risks to Weigh in Operating Margin Above 30 Per Cent Stocks

Being careful with operating margin above 30 per cent stocks means looking at what can slow the story as well as what can speed it up. Four points matter most:

• Past growth may not repeat.
• Share prices can move sharply in either direction.
• Valuation: Indian Hotels trades at a PE of 47.75 against an industry PE of 36.77, so earnings need to keep growing to support the price.
• Concentration: Holding all 4 names puts the allocation in one sector, so size each position to match your risk appetite.

How to Choose Between Operating Margin Above 30 Per Cent Stocks

Picking from operating margin above 30 per cent stocks comes down to four checks, applied in order.

1. Check balance sheet strength first, and prefer a debt-to-equity ratio below 1 for non-financial companies.
2. Compare each PE with the industry PE (12.27 to 48.59) and ask whether the growth rate justifies any gap.
3. Track net profit growth, the operating margin and the return on equity in every quarterly result.
4. Stagger entries across quarters and review institutional holding every reporting season.

Download the Univest iOS App or Univest Android App to track Sun Pharma, HAL, Hindustan Zinc and Indian Hotels live prices.

Conclusion

Among operating margin above 30 per cent stocks, Sun Pharma stands out for the fastest profit growth, 35.75% a year since FY22, HAL for a nearly debt-free balance sheet, with a debt-to-equity ratio of 0.00, Hindustan Zinc for the highest return on equity at 61.13% and Indian Hotels for the biggest five-year price gain at 658.38%. Which one suits a portfolio depends on how much valuation risk it can carry, so staggering entries and reviewing each quarterly result is a sound habit. Investors comparing operating margin above 30 per cent stocks should rank them on growth, financial strength and the price paid, and anyone who wants personalised guidance can consult a SEBI-registered advisor before acting.

Frequently Asked Questions on Operating Margin Above 30 Per Cent Stocks to Watch

Which are the best operating margin above 30 per cent stocks to watch for multibagger potential?

Ans. Sun Pharma, HAL, Hindustan Zinc and Indian Hotels are the 4 names this list highlights, with market caps of Rs 4,18,102 crore, Rs 3,26,218 crore, Rs 2,14,904 crore and Rs 1,10,254 crore respectively. Sun Pharma is notable for the fastest profit growth, 35.75% a year since FY22. HAL stands out for a nearly debt-free balance sheet, with a debt-to-equity ratio of 0.00. Hindustan Zinc offers the highest return on equity at 61.13%. Indian Hotels brings the biggest five-year price gain at 658.38%. These are watchlist names for operating margin above 30 per cent stocks, not recommendations, so match each one to your own risk profile and time horizon.

Is Hindustan Zinc a good stock for long-term investors?

Ans. Hindustan Zinc has a return on equity of 61.13%, a PE of 12.59 against an industry PE of 12.27 and a market cap of Rs 2,14,904 crore. Net profit has compounded at 9.48% a year since FY22, and FY26 revenue rose 19.59% while June 2026 quarter net profit grew 144.81%. Long-term returns in operating margin above 30 per cent stocks depend on earnings growth and the price paid at entry, so staggering purchases and consulting a SEBI-registered advisor is sensible.

Can Sun Pharma become a multibagger from here?

Ans. Sun Pharma has already gained 110.81% in five years, so another multi-fold move would need sustained earnings growth. A multibagger outcome in operating margin above 30 per cent stocks requires earnings to keep growing faster than the market for several years. Net profit has compounded at 35.75% a year since FY22, and FY26 revenue rose 12.69%. At a PE of 34.50 against an industry PE of 36.42, valuation should be checked against that growth before investing.

What is the market cap of Sun Pharma, HAL, Hindustan Zinc and Indian Hotels?

Ans. As of 26 October 2026, Sun Pharma has a market cap of Rs 4,18,102 crore, HAL has a market cap of Rs 3,26,218 crore, Hindustan Zinc has a market cap of Rs 2,14,904 crore and Indian Hotels has a market cap of Rs 1,10,254 crore. All of them qualify as largecaps. Market cap changes daily with the share price, so check the latest figure on the Univest Screener or on NSE before taking a decision on operating margin above 30 per cent stocks.

What are the risks of investing in operating margin above 30 per cent stocks?

Ans. The main risks are market swings, slower growth than expected and valuations that already reflect good news. Companies with strong balance sheets and steady earnings handle these better. Indian Hotels trades at a PE of 47.75 against an industry PE of 36.77, so earnings growth needs to hold up.

Why is Indian Hotels trading at a PE of 47.75?

Ans. Indian Hotels' PE of 47.75 compares with an industry PE of 36.77. The market is paying a premium for a return on equity of 15.97%, latest-quarter profit growth of 22.39% and FY26 revenue growth of 16.42%, which also means the stock is more sensitive if growth slows. Investors in operating margin above 30 per cent stocks who are comfortable with higher valuation risk may prefer to stagger purchases instead of investing in one go.

How much do institutions hold in Sun Pharma, HAL, Hindustan Zinc and Indian Hotels?

Ans. As of the latest reported quarter, FII and DII together hold 36.63% of Sun Pharma (14.36% and 22.27%), 21.98% of HAL (9.42% and 12.56%), 7.21% of Hindustan Zinc (2.36% and 4.85%) and 46.30% of Indian Hotels (21.71% and 24.59%). Rising institutional holding is a useful signal in operating margin above 30 per cent stocks, though it should be read with earnings trends rather than on its own.